nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Diclofenamide—glaucoma	0.0672	0.354	CbGbCtD
Capecitabine—CYP2C9—Dorzolamide—glaucoma	0.0649	0.342	CbGbCtD
Capecitabine—CYP2C9—Methazolamide—glaucoma	0.0579	0.305	CbGbCtD
Capecitabine—DPYD—Nucleotide metabolism—TXN—glaucoma	0.00404	0.046	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—TXN—glaucoma	0.0036	0.041	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00351	0.04	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00313	0.0356	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—ATOH7—glaucoma	0.00289	0.033	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—TXN—glaucoma	0.00288	0.0328	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—MMP1—glaucoma	0.00253	0.0288	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—MTHFR—glaucoma	0.0025	0.0285	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00194	0.0221	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00184	0.021	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—glaucoma	0.00179	0.0204	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00162	0.0185	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC6A13—glaucoma	0.00156	0.0178	CbGpPWpGaD
Capecitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00147	0.0168	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—TXN—glaucoma	0.00147	0.0168	CbGpPWpGaD
Capecitabine—TYMS—One Carbon Metabolism—MTHFR—glaucoma	0.00146	0.0166	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—glaucoma	0.00133	0.0152	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—VEGFA—glaucoma	0.00132	0.015	CbGpPWpGaD
Capecitabine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—glaucoma	0.00131	0.0149	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TXN—glaucoma	0.00128	0.0146	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00128	0.0146	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—glaucoma	0.00119	0.0135	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA5A—glaucoma	0.00117	0.0133	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NARFL—glaucoma	0.00117	0.0133	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—OPN4—glaucoma	0.00115	0.0131	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC6A1—glaucoma	0.00114	0.0131	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA5A—glaucoma	0.00104	0.0118	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NARFL—glaucoma	0.00104	0.0118	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—TP53—glaucoma	0.000998	0.0114	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—glaucoma	0.000949	0.0108	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB2—glaucoma	0.000933	0.0106	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NARFL—glaucoma	0.000831	0.00947	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA5A—glaucoma	0.000831	0.00947	CbGpPWpGaD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000749	0.00854	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—glaucoma	0.0007	0.00797	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—glaucoma	0.000666	0.00759	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—GSTM1—glaucoma	0.000634	0.00723	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN1B—glaucoma	0.00059	0.00672	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA1—glaucoma	0.000569	0.00649	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CTSA—glaucoma	0.000551	0.00628	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000551	0.00628	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000545	0.00621	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00054	0.00616	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CA2—glaucoma	0.000521	0.00593	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000509	0.00581	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000508	0.00579	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA1—glaucoma	0.000507	0.00578	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000494	0.00563	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CTSA—glaucoma	0.000491	0.0056	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.000485	0.00553	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.000483	0.00551	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CA2—glaucoma	0.000464	0.00529	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.000462	0.00527	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—RAB8A—glaucoma	0.000454	0.00518	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.00044	0.00502	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CA5A—glaucoma	0.000425	0.00484	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NARFL—glaucoma	0.000425	0.00484	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.00041	0.00468	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.000409	0.00467	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000406	0.00463	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA1—glaucoma	0.000406	0.00462	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—OPTN—glaucoma	0.000394	0.00449	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CTSA—glaucoma	0.000393	0.00448	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.00039	0.00445	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000374	0.00427	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000374	0.00426	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000372	0.00424	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CA2—glaucoma	0.000371	0.00423	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TXN—glaucoma	0.000367	0.00418	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000356	0.00405	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TXN—glaucoma	0.000327	0.00373	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000323	0.00369	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000319	0.00364	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000318	0.00363	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000306	0.00348	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CDKN1B—glaucoma	0.000297	0.00339	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTT1—glaucoma	0.000284	0.00324	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000283	0.00322	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000272	0.0031	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000262	0.00299	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TXN—glaucoma	0.000261	0.00298	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTT1—glaucoma	0.000254	0.00289	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.00025	0.00285	CbGpPWpGaD
Capecitabine—Arrhythmia—Betaxolol—glaucoma	0.000248	0.000343	CcSEcCtD
Capecitabine—Feeling abnormal—Dorzolamide—glaucoma	0.000247	0.000342	CcSEcCtD
Capecitabine—Decreased appetite—Pilocarpine—glaucoma	0.000247	0.000341	CcSEcCtD
Capecitabine—Feeling abnormal—Travoprost—glaucoma	0.000246	0.000341	CcSEcCtD
Capecitabine—Conjunctivitis—Timolol—glaucoma	0.000245	0.00034	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000245	0.00034	CcSEcCtD
Capecitabine—Alopecia—Betaxolol—glaucoma	0.000245	0.00034	CcSEcCtD
Capecitabine—Palpitations—Clonidine—glaucoma	0.000245	0.00034	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000245	0.000339	CcSEcCtD
Capecitabine—Gastrointestinal pain—Travoprost—glaucoma	0.000244	0.000338	CcSEcCtD
Capecitabine—Loss of consciousness—Clonidine—glaucoma	0.000244	0.000338	CcSEcCtD
Capecitabine—Feeling abnormal—Brinzolamide—glaucoma	0.000243	0.000337	CcSEcCtD
Capecitabine—Mental disorder—Betaxolol—glaucoma	0.000243	0.000337	CcSEcCtD
Capecitabine—Constipation—Pilocarpine—glaucoma	0.000243	0.000336	CcSEcCtD
Capecitabine—Pain—Pilocarpine—glaucoma	0.000243	0.000336	CcSEcCtD
Capecitabine—Cough—Clonidine—glaucoma	0.000242	0.000335	CcSEcCtD
Capecitabine—Dizziness—Apraclonidine—glaucoma	0.000242	0.000335	CcSEcCtD
Capecitabine—Malnutrition—Betaxolol—glaucoma	0.000242	0.000334	CcSEcCtD
Capecitabine—Erythema—Betaxolol—glaucoma	0.000242	0.000334	CcSEcCtD
Capecitabine—Urticaria—Dorzolamide—glaucoma	0.000238	0.00033	CcSEcCtD
Capecitabine—Epistaxis—Timolol—glaucoma	0.000238	0.00033	CcSEcCtD
Capecitabine—Body temperature increased—Dorzolamide—glaucoma	0.000237	0.000328	CcSEcCtD
Capecitabine—Abdominal pain—Dorzolamide—glaucoma	0.000237	0.000328	CcSEcCtD
Capecitabine—Dysgeusia—Betaxolol—glaucoma	0.000237	0.000328	CcSEcCtD
Capecitabine—Chest pain—Clonidine—glaucoma	0.000236	0.000327	CcSEcCtD
Capecitabine—Arthralgia—Clonidine—glaucoma	0.000236	0.000327	CcSEcCtD
Capecitabine—Abdominal pain—Travoprost—glaucoma	0.000236	0.000327	CcSEcCtD
Capecitabine—Agranulocytosis—Timolol—glaucoma	0.000236	0.000326	CcSEcCtD
Capecitabine—Anxiety—Clonidine—glaucoma	0.000235	0.000326	CcSEcCtD
Capecitabine—Asthenia—Acetazolamide—glaucoma	0.000235	0.000325	CcSEcCtD
Capecitabine—Dizziness—Bimatoprost—glaucoma	0.000235	0.000325	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000235	0.000325	CcSEcCtD
Capecitabine—Urticaria—Brinzolamide—glaucoma	0.000234	0.000325	CcSEcCtD
Capecitabine—Feeling abnormal—Pilocarpine—glaucoma	0.000234	0.000324	CcSEcCtD
Capecitabine—Discomfort—Clonidine—glaucoma	0.000233	0.000323	CcSEcCtD
Capecitabine—Vomiting—Apraclonidine—glaucoma	0.000233	0.000322	CcSEcCtD
Capecitabine—Muscle spasms—Betaxolol—glaucoma	0.000232	0.000322	CcSEcCtD
Capecitabine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000232	0.000321	CcSEcCtD
Capecitabine—Hypersensitivity—Brimonidine—glaucoma	0.000232	0.000321	CcSEcCtD
Capecitabine—Dry mouth—Clonidine—glaucoma	0.000231	0.00032	CcSEcCtD
Capecitabine—Bradycardia—Timolol—glaucoma	0.000231	0.00032	CcSEcCtD
Capecitabine—Dermatitis—Apraclonidine—glaucoma	0.000231	0.000319	CcSEcCtD
Capecitabine—Headache—Apraclonidine—glaucoma	0.000229	0.000317	CcSEcCtD
Capecitabine—Confusional state—Clonidine—glaucoma	0.000228	0.000316	CcSEcCtD
Capecitabine—Vision blurred—Betaxolol—glaucoma	0.000228	0.000315	CcSEcCtD
Capecitabine—Rhinitis—Timolol—glaucoma	0.000227	0.000315	CcSEcCtD
Capecitabine—DPYD—Metabolism—ABCA1—glaucoma	0.000227	0.00258	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1B1—glaucoma	0.000227	0.00258	CbGpPWpGaD
Capecitabine—Oedema—Clonidine—glaucoma	0.000226	0.000314	CcSEcCtD
Capecitabine—Tremor—Betaxolol—glaucoma	0.000226	0.000313	CcSEcCtD
Capecitabine—Asthenia—Brimonidine—glaucoma	0.000225	0.000312	CcSEcCtD
Capecitabine—Infection—Clonidine—glaucoma	0.000225	0.000311	CcSEcCtD
Capecitabine—Abdominal pain—Pilocarpine—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—Body temperature increased—Pilocarpine—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—Ill-defined disorder—Betaxolol—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—Diarrhoea—Acetazolamide—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—Rash—Bimatoprost—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—Dermatitis—Bimatoprost—glaucoma	0.000224	0.00031	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000224	0.00255	CbGpPWpGaD
Capecitabine—Oedema peripheral—Timolol—glaucoma	0.000223	0.000309	CcSEcCtD
Capecitabine—Anaemia—Betaxolol—glaucoma	0.000223	0.000309	CcSEcCtD
Capecitabine—Shock—Clonidine—glaucoma	0.000223	0.000308	CcSEcCtD
Capecitabine—Connective tissue disorder—Timolol—glaucoma	0.000223	0.000308	CcSEcCtD
Capecitabine—Pruritus—Brimonidine—glaucoma	0.000222	0.000308	CcSEcCtD
Capecitabine—Headache—Bimatoprost—glaucoma	0.000222	0.000308	CcSEcCtD
Capecitabine—Nervous system disorder—Clonidine—glaucoma	0.000222	0.000307	CcSEcCtD
Capecitabine—Thrombocytopenia—Clonidine—glaucoma	0.000222	0.000307	CcSEcCtD
Capecitabine—Hypersensitivity—Dorzolamide—glaucoma	0.000221	0.000306	CcSEcCtD
Capecitabine—Tachycardia—Clonidine—glaucoma	0.000221	0.000306	CcSEcCtD
Capecitabine—Hypersensitivity—Travoprost—glaucoma	0.00022	0.000305	CcSEcCtD
Capecitabine—Skin disorder—Clonidine—glaucoma	0.00022	0.000305	CcSEcCtD
Capecitabine—Hyperhidrosis—Clonidine—glaucoma	0.000219	0.000303	CcSEcCtD
Capecitabine—Visual impairment—Timolol—glaucoma	0.000218	0.000302	CcSEcCtD
Capecitabine—Malaise—Betaxolol—glaucoma	0.000218	0.000302	CcSEcCtD
Capecitabine—Nausea—Apraclonidine—glaucoma	0.000217	0.000301	CcSEcCtD
Capecitabine—Hypersensitivity—Brinzolamide—glaucoma	0.000217	0.000301	CcSEcCtD
Capecitabine—Vertigo—Betaxolol—glaucoma	0.000217	0.000301	CcSEcCtD
Capecitabine—Syncope—Betaxolol—glaucoma	0.000217	0.0003	CcSEcCtD
Capecitabine—Dizziness—Acetazolamide—glaucoma	0.000217	0.0003	CcSEcCtD
Capecitabine—Anorexia—Clonidine—glaucoma	0.000216	0.000299	CcSEcCtD
Capecitabine—Asthenia—Dorzolamide—glaucoma	0.000215	0.000298	CcSEcCtD
Capecitabine—Asthenia—Travoprost—glaucoma	0.000214	0.000297	CcSEcCtD
Capecitabine—Palpitations—Betaxolol—glaucoma	0.000213	0.000296	CcSEcCtD
Capecitabine—Pruritus—Dorzolamide—glaucoma	0.000212	0.000294	CcSEcCtD
Capecitabine—Loss of consciousness—Betaxolol—glaucoma	0.000212	0.000294	CcSEcCtD
Capecitabine—Eye disorder—Timolol—glaucoma	0.000212	0.000293	CcSEcCtD
Capecitabine—Asthenia—Brinzolamide—glaucoma	0.000212	0.000293	CcSEcCtD
Capecitabine—Hypotension—Clonidine—glaucoma	0.000212	0.000293	CcSEcCtD
Capecitabine—Pruritus—Travoprost—glaucoma	0.000211	0.000293	CcSEcCtD
Capecitabine—Tinnitus—Timolol—glaucoma	0.000211	0.000293	CcSEcCtD
Capecitabine—Cough—Betaxolol—glaucoma	0.000211	0.000292	CcSEcCtD
Capecitabine—Nausea—Bimatoprost—glaucoma	0.000211	0.000292	CcSEcCtD
Capecitabine—Cardiac disorder—Timolol—glaucoma	0.00021	0.000291	CcSEcCtD
Capecitabine—Hypersensitivity—Pilocarpine—glaucoma	0.000209	0.000289	CcSEcCtD
Capecitabine—Pruritus—Brinzolamide—glaucoma	0.000209	0.000289	CcSEcCtD
Capecitabine—Vomiting—Acetazolamide—glaucoma	0.000208	0.000288	CcSEcCtD
Capecitabine—Dizziness—Brimonidine—glaucoma	0.000208	0.000288	CcSEcCtD
Capecitabine—TYMS—Metabolism—CA1—glaucoma	0.000207	0.00237	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000206	0.000286	CcSEcCtD
Capecitabine—Angiopathy—Timolol—glaucoma	0.000206	0.000285	CcSEcCtD
Capecitabine—Arthralgia—Betaxolol—glaucoma	0.000206	0.000285	CcSEcCtD
Capecitabine—Chest pain—Betaxolol—glaucoma	0.000206	0.000285	CcSEcCtD
Capecitabine—Myalgia—Betaxolol—glaucoma	0.000206	0.000285	CcSEcCtD
Capecitabine—Diarrhoea—Dorzolamide—glaucoma	0.000205	0.000284	CcSEcCtD
Capecitabine—Headache—Acetazolamide—glaucoma	0.000205	0.000284	CcSEcCtD
Capecitabine—Anxiety—Betaxolol—glaucoma	0.000205	0.000284	CcSEcCtD
Capecitabine—Insomnia—Clonidine—glaucoma	0.000205	0.000284	CcSEcCtD
Capecitabine—Immune system disorder—Timolol—glaucoma	0.000205	0.000284	CcSEcCtD
Capecitabine—Diarrhoea—Travoprost—glaucoma	0.000204	0.000283	CcSEcCtD
Capecitabine—Mediastinal disorder—Timolol—glaucoma	0.000204	0.000283	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000204	0.000283	CcSEcCtD
Capecitabine—Asthenia—Pilocarpine—glaucoma	0.000203	0.000282	CcSEcCtD
Capecitabine—Paraesthesia—Clonidine—glaucoma	0.000203	0.000282	CcSEcCtD
Capecitabine—Discomfort—Betaxolol—glaucoma	0.000203	0.000281	CcSEcCtD
Capecitabine—TYMP—Metabolism—GSTT1—glaucoma	0.000203	0.00231	CbGpPWpGaD
Capecitabine—Arrhythmia—Timolol—glaucoma	0.000203	0.00028	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.000202	0.0023	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCA1—glaucoma	0.000202	0.0023	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1B1—glaucoma	0.000202	0.0023	CbGpPWpGaD
Capecitabine—Dyspnoea—Clonidine—glaucoma	0.000202	0.00028	CcSEcCtD
Capecitabine—Diarrhoea—Brinzolamide—glaucoma	0.000202	0.00028	CcSEcCtD
Capecitabine—Dry mouth—Betaxolol—glaucoma	0.000201	0.000278	CcSEcCtD
Capecitabine—TYMS—Metabolism—CTSA—glaucoma	0.000201	0.00229	CbGpPWpGaD
Capecitabine—Pruritus—Pilocarpine—glaucoma	0.000201	0.000278	CcSEcCtD
Capecitabine—Alopecia—Timolol—glaucoma	0.0002	0.000277	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.0002	0.00228	CbGpPWpGaD
Capecitabine—Confusional state—Betaxolol—glaucoma	0.000199	0.000275	CcSEcCtD
Capecitabine—Mental disorder—Timolol—glaucoma	0.000199	0.000275	CcSEcCtD
Capecitabine—Dizziness—Dorzolamide—glaucoma	0.000198	0.000275	CcSEcCtD
Capecitabine—Rash—Brimonidine—glaucoma	0.000198	0.000274	CcSEcCtD
Capecitabine—Dermatitis—Brimonidine—glaucoma	0.000198	0.000274	CcSEcCtD
Capecitabine—Dizziness—Travoprost—glaucoma	0.000198	0.000274	CcSEcCtD
Capecitabine—Erythema—Timolol—glaucoma	0.000197	0.000273	CcSEcCtD
Capecitabine—Malnutrition—Timolol—glaucoma	0.000197	0.000273	CcSEcCtD
Capecitabine—Oedema—Betaxolol—glaucoma	0.000197	0.000273	CcSEcCtD
Capecitabine—Headache—Brimonidine—glaucoma	0.000197	0.000273	CcSEcCtD
Capecitabine—Decreased appetite—Clonidine—glaucoma	0.000197	0.000273	CcSEcCtD
Capecitabine—Infection—Betaxolol—glaucoma	0.000196	0.000271	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Clonidine—glaucoma	0.000196	0.000271	CcSEcCtD
Capecitabine—Fatigue—Clonidine—glaucoma	0.000195	0.00027	CcSEcCtD
Capecitabine—Dizziness—Brinzolamide—glaucoma	0.000195	0.00027	CcSEcCtD
Capecitabine—Nausea—Acetazolamide—glaucoma	0.000194	0.000269	CcSEcCtD
Capecitabine—Diarrhoea—Pilocarpine—glaucoma	0.000194	0.000269	CcSEcCtD
Capecitabine—Shock—Betaxolol—glaucoma	0.000194	0.000269	CcSEcCtD
Capecitabine—Constipation—Clonidine—glaucoma	0.000194	0.000268	CcSEcCtD
Capecitabine—Pain—Clonidine—glaucoma	0.000194	0.000268	CcSEcCtD
Capecitabine—Nervous system disorder—Betaxolol—glaucoma	0.000193	0.000268	CcSEcCtD
Capecitabine—Dysgeusia—Timolol—glaucoma	0.000193	0.000268	CcSEcCtD
Capecitabine—Thrombocytopenia—Betaxolol—glaucoma	0.000193	0.000267	CcSEcCtD
Capecitabine—Tachycardia—Betaxolol—glaucoma	0.000192	0.000266	CcSEcCtD
Capecitabine—Skin disorder—Betaxolol—glaucoma	0.000192	0.000265	CcSEcCtD
Capecitabine—Vomiting—Dorzolamide—glaucoma	0.000191	0.000264	CcSEcCtD
Capecitabine—Hyperhidrosis—Betaxolol—glaucoma	0.000191	0.000264	CcSEcCtD
Capecitabine—TYMS—Metabolism—CA2—glaucoma	0.00019	0.00216	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00019	0.00216	CbGpPWpGaD
Capecitabine—Rash—Dorzolamide—glaucoma	0.000189	0.000262	CcSEcCtD
Capecitabine—Dermatitis—Dorzolamide—glaucoma	0.000189	0.000262	CcSEcCtD
Capecitabine—Rash—Travoprost—glaucoma	0.000188	0.000261	CcSEcCtD
Capecitabine—Dermatitis—Travoprost—glaucoma	0.000188	0.000261	CcSEcCtD
Capecitabine—Headache—Dorzolamide—glaucoma	0.000188	0.00026	CcSEcCtD
Capecitabine—Anorexia—Betaxolol—glaucoma	0.000188	0.00026	CcSEcCtD
Capecitabine—Vomiting—Brinzolamide—glaucoma	0.000188	0.00026	CcSEcCtD
Capecitabine—Dizziness—Pilocarpine—glaucoma	0.000188	0.00026	CcSEcCtD
Capecitabine—Headache—Travoprost—glaucoma	0.000187	0.000259	CcSEcCtD
Capecitabine—Nausea—Brimonidine—glaucoma	0.000187	0.000258	CcSEcCtD
Capecitabine—Feeling abnormal—Clonidine—glaucoma	0.000187	0.000258	CcSEcCtD
Capecitabine—Rash—Brinzolamide—glaucoma	0.000186	0.000258	CcSEcCtD
Capecitabine—Vision blurred—Timolol—glaucoma	0.000186	0.000258	CcSEcCtD
Capecitabine—Dermatitis—Brinzolamide—glaucoma	0.000186	0.000257	CcSEcCtD
Capecitabine—Gastrointestinal pain—Clonidine—glaucoma	0.000185	0.000256	CcSEcCtD
Capecitabine—Headache—Brinzolamide—glaucoma	0.000185	0.000256	CcSEcCtD
Capecitabine—Hypotension—Betaxolol—glaucoma	0.000184	0.000255	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000181	0.00207	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—glaucoma	0.000181	0.00207	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND2—glaucoma	0.000181	0.00206	CbGpPWpGaD
Capecitabine—Vomiting—Pilocarpine—glaucoma	0.00018	0.00025	CcSEcCtD
Capecitabine—Urticaria—Clonidine—glaucoma	0.00018	0.000249	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00018	0.000249	CcSEcCtD
Capecitabine—Abdominal pain—Clonidine—glaucoma	0.000179	0.000248	CcSEcCtD
Capecitabine—Body temperature increased—Clonidine—glaucoma	0.000179	0.000248	CcSEcCtD
Capecitabine—Rash—Pilocarpine—glaucoma	0.000179	0.000248	CcSEcCtD
Capecitabine—Dermatitis—Pilocarpine—glaucoma	0.000179	0.000247	CcSEcCtD
Capecitabine—Insomnia—Betaxolol—glaucoma	0.000178	0.000247	CcSEcCtD
Capecitabine—Nausea—Dorzolamide—glaucoma	0.000178	0.000247	CcSEcCtD
Capecitabine—Headache—Pilocarpine—glaucoma	0.000178	0.000246	CcSEcCtD
Capecitabine—Nausea—Travoprost—glaucoma	0.000178	0.000246	CcSEcCtD
Capecitabine—Vertigo—Timolol—glaucoma	0.000177	0.000245	CcSEcCtD
Capecitabine—Paraesthesia—Betaxolol—glaucoma	0.000177	0.000245	CcSEcCtD
Capecitabine—Syncope—Timolol—glaucoma	0.000177	0.000245	CcSEcCtD
Capecitabine—Dyspnoea—Betaxolol—glaucoma	0.000176	0.000243	CcSEcCtD
Capecitabine—Nausea—Brinzolamide—glaucoma	0.000175	0.000243	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000175	0.00199	CbGpPWpGaD
Capecitabine—Palpitations—Timolol—glaucoma	0.000174	0.000241	CcSEcCtD
Capecitabine—Dyspepsia—Betaxolol—glaucoma	0.000174	0.00024	CcSEcCtD
Capecitabine—Loss of consciousness—Timolol—glaucoma	0.000173	0.00024	CcSEcCtD
Capecitabine—Cough—Timolol—glaucoma	0.000172	0.000238	CcSEcCtD
Capecitabine—Decreased appetite—Betaxolol—glaucoma	0.000171	0.000237	CcSEcCtD
Capecitabine—Hypertension—Timolol—glaucoma	0.00017	0.000236	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Betaxolol—glaucoma	0.00017	0.000236	CcSEcCtD
Capecitabine—Fatigue—Betaxolol—glaucoma	0.00017	0.000235	CcSEcCtD
Capecitabine—Constipation—Betaxolol—glaucoma	0.000169	0.000233	CcSEcCtD
Capecitabine—Pain—Betaxolol—glaucoma	0.000169	0.000233	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000169	0.00192	CbGpPWpGaD
Capecitabine—Nausea—Pilocarpine—glaucoma	0.000168	0.000233	CcSEcCtD
Capecitabine—Chest pain—Timolol—glaucoma	0.000168	0.000233	CcSEcCtD
Capecitabine—Myalgia—Timolol—glaucoma	0.000168	0.000233	CcSEcCtD
Capecitabine—Arthralgia—Timolol—glaucoma	0.000168	0.000233	CcSEcCtD
Capecitabine—Anxiety—Timolol—glaucoma	0.000167	0.000232	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000167	0.000231	CcSEcCtD
Capecitabine—Hypersensitivity—Clonidine—glaucoma	0.000167	0.000231	CcSEcCtD
Capecitabine—Discomfort—Timolol—glaucoma	0.000166	0.00023	CcSEcCtD
Capecitabine—Dry mouth—Timolol—glaucoma	0.000164	0.000228	CcSEcCtD
Capecitabine—Asthenia—Clonidine—glaucoma	0.000162	0.000225	CcSEcCtD
Capecitabine—Feeling abnormal—Betaxolol—glaucoma	0.000162	0.000225	CcSEcCtD
Capecitabine—Confusional state—Timolol—glaucoma	0.000162	0.000225	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000162	0.00185	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTM1—glaucoma	0.000161	0.00184	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCA1—glaucoma	0.000161	0.00184	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1B1—glaucoma	0.000161	0.00184	CbGpPWpGaD
Capecitabine—Oedema—Timolol—glaucoma	0.000161	0.000223	CcSEcCtD
Capecitabine—Pruritus—Clonidine—glaucoma	0.00016	0.000222	CcSEcCtD
Capecitabine—DPYD—Metabolism—MTHFR—glaucoma	0.00016	0.00183	CbGpPWpGaD
Capecitabine—Infection—Timolol—glaucoma	0.00016	0.000222	CcSEcCtD
Capecitabine—Shock—Timolol—glaucoma	0.000158	0.000219	CcSEcCtD
Capecitabine—Nervous system disorder—Timolol—glaucoma	0.000158	0.000219	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000158	0.0018	CbGpPWpGaD
Capecitabine—Urticaria—Betaxolol—glaucoma	0.000157	0.000217	CcSEcCtD
Capecitabine—Skin disorder—Timolol—glaucoma	0.000156	0.000217	CcSEcCtD
Capecitabine—Body temperature increased—Betaxolol—glaucoma	0.000156	0.000216	CcSEcCtD
Capecitabine—Hyperhidrosis—Timolol—glaucoma	0.000156	0.000216	CcSEcCtD
Capecitabine—Diarrhoea—Clonidine—glaucoma	0.000155	0.000215	CcSEcCtD
Capecitabine—Anorexia—Timolol—glaucoma	0.000154	0.000213	CcSEcCtD
Capecitabine—Hypotension—Timolol—glaucoma	0.000151	0.000208	CcSEcCtD
Capecitabine—Dizziness—Clonidine—glaucoma	0.00015	0.000207	CcSEcCtD
Capecitabine—DPYD—Metabolism—APOE—glaucoma	0.000149	0.0017	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAV1—glaucoma	0.000148	0.00168	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000147	0.000203	CcSEcCtD
Capecitabine—Insomnia—Timolol—glaucoma	0.000146	0.000202	CcSEcCtD
Capecitabine—Hypersensitivity—Betaxolol—glaucoma	0.000145	0.000201	CcSEcCtD
Capecitabine—Paraesthesia—Timolol—glaucoma	0.000145	0.0002	CcSEcCtD
Capecitabine—Vomiting—Clonidine—glaucoma	0.000144	0.000199	CcSEcCtD
Capecitabine—Dyspnoea—Timolol—glaucoma	0.000144	0.000199	CcSEcCtD
Capecitabine—Rash—Clonidine—glaucoma	0.000143	0.000198	CcSEcCtD
Capecitabine—CDA—Metabolism—MTHFR—glaucoma	0.000143	0.00163	CbGpPWpGaD
Capecitabine—Dermatitis—Clonidine—glaucoma	0.000143	0.000198	CcSEcCtD
Capecitabine—Headache—Clonidine—glaucoma	0.000142	0.000196	CcSEcCtD
Capecitabine—Dyspepsia—Timolol—glaucoma	0.000142	0.000196	CcSEcCtD
Capecitabine—Asthenia—Betaxolol—glaucoma	0.000141	0.000196	CcSEcCtD
Capecitabine—Decreased appetite—Timolol—glaucoma	0.00014	0.000194	CcSEcCtD
Capecitabine—Pruritus—Betaxolol—glaucoma	0.000139	0.000193	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000139	0.00159	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Timolol—glaucoma	0.000139	0.000193	CcSEcCtD
Capecitabine—Fatigue—Timolol—glaucoma	0.000139	0.000192	CcSEcCtD
Capecitabine—Pain—Timolol—glaucoma	0.000138	0.000191	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000137	0.00157	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000135	0.00154	CbGpPWpGaD
Capecitabine—Diarrhoea—Betaxolol—glaucoma	0.000135	0.000187	CcSEcCtD
Capecitabine—Nausea—Clonidine—glaucoma	0.000135	0.000186	CcSEcCtD
Capecitabine—TYMS—Metabolism—TXN—glaucoma	0.000134	0.00152	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOE—glaucoma	0.000133	0.00151	CbGpPWpGaD
Capecitabine—Feeling abnormal—Timolol—glaucoma	0.000133	0.000184	CcSEcCtD
Capecitabine—Gastrointestinal pain—Timolol—glaucoma	0.000132	0.000182	CcSEcCtD
Capecitabine—CDA—Metabolism—CAV1—glaucoma	0.000132	0.0015	CbGpPWpGaD
Capecitabine—Dizziness—Betaxolol—glaucoma	0.00013	0.000181	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00013	0.00148	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—glaucoma	0.000129	0.00147	CbGpPWpGaD
Capecitabine—Urticaria—Timolol—glaucoma	0.000128	0.000177	CcSEcCtD
Capecitabine—Abdominal pain—Timolol—glaucoma	0.000127	0.000176	CcSEcCtD
Capecitabine—Body temperature increased—Timolol—glaucoma	0.000127	0.000176	CcSEcCtD
Capecitabine—Vomiting—Betaxolol—glaucoma	0.000125	0.000174	CcSEcCtD
Capecitabine—Rash—Betaxolol—glaucoma	0.000124	0.000172	CcSEcCtD
Capecitabine—Dermatitis—Betaxolol—glaucoma	0.000124	0.000172	CcSEcCtD
Capecitabine—Headache—Betaxolol—glaucoma	0.000124	0.000171	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—NARFL—glaucoma	0.000122	0.0014	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA5A—glaucoma	0.000122	0.0014	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000119	0.00136	CbGpPWpGaD
Capecitabine—Hypersensitivity—Timolol—glaucoma	0.000119	0.000164	CcSEcCtD
Capecitabine—Nausea—Betaxolol—glaucoma	0.000117	0.000162	CcSEcCtD
Capecitabine—Asthenia—Timolol—glaucoma	0.000116	0.00016	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—glaucoma	0.000114	0.0013	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—glaucoma	0.000114	0.0013	CbGpPWpGaD
Capecitabine—Pruritus—Timolol—glaucoma	0.000114	0.000158	CcSEcCtD
Capecitabine—DPYD—Metabolism—NOS3—glaucoma	0.000112	0.00127	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000111	0.00127	CbGpPWpGaD
Capecitabine—Diarrhoea—Timolol—glaucoma	0.00011	0.000153	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.00011	0.00125	CbGpPWpGaD
Capecitabine—Dizziness—Timolol—glaucoma	0.000107	0.000147	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOE—glaucoma	0.000106	0.00121	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAV1—glaucoma	0.000105	0.0012	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTT1—glaucoma	0.000104	0.00118	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000104	0.00118	CbGpPWpGaD
Capecitabine—Vomiting—Timolol—glaucoma	0.000102	0.000142	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTGS2—glaucoma	0.000102	0.00116	CbGpPWpGaD
Capecitabine—Rash—Timolol—glaucoma	0.000102	0.000141	CcSEcCtD
Capecitabine—Dermatitis—Timolol—glaucoma	0.000101	0.00014	CcSEcCtD
Capecitabine—Headache—Timolol—glaucoma	0.000101	0.00014	CcSEcCtD
Capecitabine—CDA—Metabolism—NOS3—glaucoma	9.95e-05	0.00113	CbGpPWpGaD
Capecitabine—Nausea—Timolol—glaucoma	9.57e-05	0.000132	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2A—glaucoma	9.27e-05	0.00106	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	9.18e-05	0.00105	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—glaucoma	9.1e-05	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCA1—glaucoma	8.26e-05	0.000942	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1B1—glaucoma	8.26e-05	0.000942	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1B—glaucoma	8.21e-05	0.000936	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—glaucoma	7.96e-05	0.000907	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—glaucoma	7.28e-05	0.00083	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—glaucoma	6.6e-05	0.000753	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA1—glaucoma	5.98e-05	0.000682	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—glaucoma	5.84e-05	0.000665	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CTSA—glaucoma	5.79e-05	0.00066	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CA2—glaucoma	5.47e-05	0.000624	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOE—glaucoma	5.43e-05	0.000619	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAV1—glaucoma	5.38e-05	0.000614	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.35e-05	0.000609	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.35e-05	0.000609	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—glaucoma	5.16e-05	0.000588	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—glaucoma	4.07e-05	0.000464	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TXN—glaucoma	3.85e-05	0.000439	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—glaucoma	3.72e-05	0.000424	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.52e-05	0.000401	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.48e-05	0.000397	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—glaucoma	2.99e-05	0.000341	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.41e-05	0.000275	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCA1—glaucoma	2.38e-05	0.000271	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1B1—glaucoma	2.38e-05	0.000271	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—glaucoma	1.9e-05	0.000217	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—glaucoma	1.68e-05	0.000192	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—glaucoma	1.57e-05	0.000179	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAV1—glaucoma	1.55e-05	0.000177	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—glaucoma	1.17e-05	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—glaucoma	1.07e-05	0.000122	CbGpPWpGaD
